Consequently, the IHC analysis of the tumor sections confirmed a reduction in the endomucin staining, which marks endothelial cells, in SVZ-vIII (Fig. 5b) but not in GL261 (Fig. 5c) tumors in the presence of the drug. Here, EMCN is linked to neoplasm.